Published in N Z Med J on December 08, 1982
Systematic review of long term effects of advice to reduce dietary salt in adults. BMJ (2002) 3.87
By how much does dietary salt reduction lower blood pressure? III--Analysis of data from trials of salt reduction. BMJ (1991) 3.47
Reduced dietary salt for the prevention of cardiovascular disease. Cochrane Database Syst Rev (2011) 2.38
Cost and health consequences of reducing the population intake of salt. J Epidemiol Community Health (2000) 1.62
Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension: a double blind study. Br Med J (Clin Res Ed) (1987) 1.04
Beta-adrenergic receptor blocking drugs in hypertension. Drugs (1974) 2.18
Management of raised blood pressure. N Z Med J (1994) 2.03
Prazosin in normal subjects: plasma levels, blood pressure and heart rate. Br J Clin Pharmacol (1976) 1.75
Cardiovascular effects of prazosin in normotensive and genetically hypertensive rats. Clin Exp Pharmacol Physiol (1975) 1.63
The Milton survey: Part 1, General methods, height, weight and 24-hour excretion of sodium, potassium, calcium, magnesium and creatinine. N Z Med J (1978) 1.55
The use of p-phenylenediamine in the block to enhance osmium staining for electron microscopy. Stain Technol (1972) 1.47
The New Zealand strain of rats with genetic hypertension. N Z Med J (1968) 1.45
The relationship between the transverse tubular system and other tubules at the Z disc levels of myocardial cells in the ferret. Am J Anat (1968) 1.42
Surface features of striated muscle. II. Guinea-pig skeletal muscle. J Cell Sci (1968) 1.34
Practolol treatment in asthmatics. Lancet (1971) 1.30
The prevalence of headache in a small New Zealand town. Headache (1985) 1.22
The fine structure of autonomic neuromuscular contacts in arterioles of sheep renal cortex. J Anat (1966) 1.21
Cigarettes and accelerated hypertension. N Z Med J (1980) 1.19
Surface features of smooth muscle cells from the mesenteric artery and vas deferens. J Cell Sci (1971) 1.14
Surface features of striated muscle. I. Guinea-pig cardiac muscle. J Cell Sci (1968) 1.06
Letter: Paradoxical effect of pindolol. Br Med J (1975) 1.03
Freeze-etch studies on fish skeletal muscle. J Cell Sci (1970) 1.02
Ultrastructure of desmosomes in mammalian intercalated disc; appearances after lanthanum treatment. J Cell Biol (1969) 1.00
A preliminary clinical trial of Prazosin: a new oral antihypertensive agent. N Z Med J (1974) 0.99
The fine structure of vascular sympathetic neuromuscular contacts in the rat. Am J Anat (1967) 0.99
Transverse tubule apertures in mammalian myocardial cells: surface array. Science (1967) 0.98
Beta-blockers and lipid metabolism. Br Med J (1977) 0.98
Long-lasting peripheral and central effects of 6-hydroxydopamine in rats. Br J Pharmacol (1972) 0.98
Experience with labetalol in hypertension. Br J Clin Pharmacol (1976) 0.97
Treatment of hypertension with labetalol. N Z Med J (1977) 0.97
Congenital Abnormalities of the Heart in the Insane. J Anat Physiol (1898) 0.96
Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial. N Z Med J (1974) 0.95
Ticrynafen: kinetics, protein binding, and effects on serum and urinary uric acid. Clin Pharmacol Ther (1978) 0.93
Different associations of blood pressure with 24-hour urinary sodium excretion among pre- and post-menopausal women. WHO Cardiovascular Diseases and Alimentary Comparison (WHO-CARDIAC) Study. J Hypertens (2001) 0.93
Localization of tritiated norepinephrine in vascular sympathetic axons of the rat intestine and mesentery by electron microscope radioautography. J Cell Biol (1968) 0.92
Comparison of tienilic acid with cyclopenthiazide in hyperuricaemic hypertensive patients. Lancet (1978) 0.91
Further surveys in Milton, 1978 and 1981: blood pressure, height, weight and 24-hour excretion of sodium and potassium. N Z Med J (1982) 0.91
Salt and hypertension: a sceptical review of the evidence. Clin Sci (Lond) (1979) 0.91
The Milton Survey. 2. Blood pressure and heart rate. N Z Med J (1978) 0.90
The Spielberger Anger Expression Scale: some psychometric data. Br J Clin Psychol (1988) 0.90
Plasma volume, extracellular fluid volume and exchangeable sodium concentrations in the New Zealand strain of genetically hypertensive rat. Clin Sci (1973) 0.89
Relationship of blood pressure to sodium excretion in a population survey. Clin Sci Mol Med Suppl (1978) 0.88
Heart mass and blood pressure have separate genetic determinants in the New Zealand genetically hypertensive (GH) rat. J Hypertens (1995) 0.88
Salt and hypertension: current data, attitudes, and policies. J Cardiovasc Pharmacol (1984) 0.88
Fenfluramine in obese patients on various antihypertensive drugs. Double-blind controlled trial. Lancet (1969) 0.87
Cardiovascular reactivity in rats with spontaneous inherited hypertension and constricted renal artery hypertension. Am Heart J (1966) 0.87
Effects of different diuretics on urinary calcium excretion in a general population. Aust N Z J Med (1978) 0.85
Clinical studies with ketanserin in hypertension. J Cardiovasc Pharmacol (1985) 0.85
Myofilaments in frozen-etched muscle. Nature (1968) 0.84
The morphological basis for the sympathetic control of blood vessels. N Z Med J (1968) 0.84
Sodium, potassium and water in the tissues of rats with genetic hypertension and constricted renal artery hypertension. Clin Sci (1968) 0.84
Hypertension and depression: interrelated problems in therapy. J R Coll Physicians Lond (1971) 0.82
Effects of prazosin in patients with hypertension. Clin Pharmacol Ther (1976) 0.82
Effects of arm position and support on blood-pressure readings. J Clin Hypertens (1987) 0.81
Alcohol consumption and blood pressure in a New Zealand community study. N Z Med J (1985) 0.80
Selenium and risk factors for cardiovascular disease in New Zealand. N Z Med J (1983) 0.80
Salt appetite, body sodium, handling of a NaCl load, renin, and aldosterone in genetically and spontaneously hypertensive rats. J Cardiovasc Pharmacol (1990) 0.79
Clonidine in menopausal flushing: a double-blind trial. N Z Med J (1975) 0.79
Iodide excretion in a salt-restriction trial. N Z Med J (1984) 0.79
Freeze-etch studies on the innervation of mesenteric arteries and vas deferens. J Cell Sci (1971) 0.79
One year follow-up of hyperuricaemic hypertensive patients treated with tienilic acid or a diuretic with or without uric acid-lowering drugs. Clin Sci (Lond) (1979) 0.78
Genetic and autonomic factors in inherited hypertension. Circ Res (1970) 0.78
Total ban on tienilic acid. Lancet (1980) 0.78
Use of prazosin at the dunedin hypertension clinic controlled and open studies and pharmacokinetic observations. Med J Aust (1977) 0.78
Review of long-term treatment with labetalol. Br J Clin Pharmacol (1982) 0.78
FINE STRUCTURE OF CELLS ISOLATED FROM ADULT MOUSE LIVER. J Cell Biol (1962) 0.78
Sodium supplements, blood pressure, and calcium channel blocking drugs. Lancet (1987) 0.77
Discriminant function analysis of factors related to myocardial infarction in male patients on antihypertensive therapy. Br Heart J (1976) 0.77
Studies on the New Zealand strain of genetically hypertensive rats. Clin Sci Mol Med Suppl (1973) 0.77
Monovalent and divalent cations in hypertension. Prev Med (1985) 0.77
Intracellular cations and transmembrane cation transport in essential hypertension: the importance of controlled clinical observations. J Hypertens (1986) 0.77
Licorice consumption among high school students. N Z Med J (1982) 0.76
Control of hindlimb vascular resistance in rats chronically sympathectomized with 6-hydroxydopamine. Clin Exp Pharmacol Physiol (1978) 0.76
Comparison of various genetic hypertensive rat strains. J Hypertens Suppl (1986) 0.76
Evidence against a circulating ouabain-like transport inhibitor as a cause of increased red cell sodium in essential hypertension. J Hypertens Suppl (1984) 0.75
Hypertension. Br Med J (1978) 0.75
Bundles of intracellular tubules in renal medullary interstitial cells. J Cell Biol (1973) 0.75
Guidelines for antihypertensive therapy: problems with a strategy based on absolute cardiovascular risk, reply to comments. J Hypertens (1997) 0.75
Letter: New vasodilator drugs for hypertension. Br Med J (1974) 0.75
Evidence for safety of new drugs. Br J Clin Pharmacol (1977) 0.75
MRC trial of treatment of mild hypertension. Br Med J (Clin Res Ed) (1985) 0.75
Increased plasma volume in hypertensive rats with polyarteritis. Br J Exp Pathol (1974) 0.75
The management of hypertension. N Z Med J (1995) 0.75
Relationship of treatment for hypertension and stroke mortality. Stroke (1989) 0.75
Renal vasculature and hypertensive mechanisms. Histological aspects. Circ Res (1970) 0.75
Eight-year survival study of treated hypertension at the Dunedin Hypertension Clinic 1953-1977. J Hypertens Suppl (1988) 0.75
Intensification of osmium staining by p-phenylenediamine: paraffin and epon embedding; lipid granules in renal medulla. Stain Technol (1970) 0.75
The structural basis for excitation-contraction coupling in mammalian myocardial cells. Isr J Med Sci (1969) 0.75
The evolution of antihypertensive therapy. N Z Med J (1968) 0.75